Dexcom gets a new Buy rating at Benchmark on expected margin expansion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 77.94 -0.38 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.32 | 52 Week High | $96.38 | |||
| Open | $78.68 | 52 Week Low | $47.92 | |||
| Day High | $79.51 | P/E | N/A | |||
| Day Low | $77.82 | EPS | $-0.42 | |||
| Volume | 5,218,325 | |||||
